Some medicines are super useful. They might be natural compounds, like an isoflavone called puerarin. But here's a big problem: the body struggles to absorb them when you take them by mouth. These molecules often don't dissolve well or they can't pass through your gut lining easily. Scientists need
Bitcoin stayed near $61, 000 after a rough week of trading. The price fell below $60, 000 last week – the lowest it’s hit since October 2024 and more than half of its all‑time peak in 2023. Experts warn that the downturn could continue, especially as money moves toward new tech offerings like
Bitcoin keeps sending mixed signals as summer approaches. One expert warns investors to pause before jumping back in. His fund stays cautious on digital money, pointing to several warning signs. Digital cash faces big problems beyond price swings. Companies still hold large amounts of crypto, creat
Jefferies forecasts that the next two years could bring a surge of crypto‑related public offerings, potentially expanding into a $1 trillion market within five years. The bank’s outlook follows its first Digital Assets Investor Conference, where executives from 35 digital‑asset firms met about 15
Scientists have built a new kind of tiny bubble that can sneak into stubborn bacterial layers and burn them away with light. The bubble is wrapped in a sugar shell made of hyaluronic acid, a substance that naturally appears in our skin. When the bubble reaches an infected wound, enzymes called hyalu
Body fat isn’t just a passive backdrop; it actively influences how men experience erectile function. Recent research shows that excess weight can trigger hormonal changes, inflammation, and blood flow problems that directly impair the ability to achieve or maintain an erection. Rather than seeing
The Texas Stock Exchange, a new player on the trading scene, has set its sights on launching initial public offerings during early 2027. The goal is to capture business that has traditionally gone to larger venues such as Nasdaq and the New York Stock Exchange. The exchange will start trading thi
Two biotech firms are trying to cash in on investor excitement around obesity drugs and disease-detecting technology. One company wants $533 million to develop weight-loss treatments, while another seeks $159 million to expand its diagnostic tools. Both plan to sell shares to the public soon, hoping
Children who grow up with Congenital Adrenal Hyperplasia (CAH) caused by a 21‑hydroxylase enzyme problem often show changes in body weight that differ from their peers. Scientists track a key moment called adiposity rebound, when the body mass index (BMI) stops falling and begins to climb again a
Many people saw crypto companies crash after Bitcoin fell, but experts think new public offerings could still happen next year. Kraken, a big exchange, has already filed for an IPO secretly this year. The company that owns the popular wallet MetaMask, Consenys, and Ledger, a maker of hardware wa
